Kigamicin D, a novel anticancer agent based on a new anti‐austerity strategy targeting cancer cells' tolerance to nutrient starvation
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Both tolerance to nutrient starvation and angiogenesis are esse tial for cancer progression because of the insufficient supply of nutrients to tumor tissue. Since chronic nutrient starvation seldom occurs in normal tissue, cancer's tolerance to nutrient starvation should provide a novel target for cancer therapy. In this study, we propose an anti‐austerity strategy to exploit the ability of agents to eliminate cancer cells' tolerance to nutrient starvation. We established a simple screening method for agents that inhibit cancer cell viability preferentially during nutrient starvation, using PANC‐1 cell line cultured in nutrient‐rich and nutrien deprived media. After screening over 2000 culture media of act nomycetes, we identified a new compound, kigamicin (C 48 H 59 NO 19), which shows preferential cytotoxicity to cancer ceels under nutrient‐deprived conditions, but hardly any cytotoxici under nutrient‐rich conditions. Both subcutaneous and oral a ministration of kigamicin D strongly suppressed the tumor growth of several tested pancreatic cancer cell lines in nude mice Moreover, kigamicin D was observed to block the activation of Akt induced by nutrient starvation. Therefore, our results sugge that kigamicin D be a candidate for implementing our novel concept, anti‐austerity, which may serve as a new strategy for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of normal and tumor-derived angiogenesis
Papetti, M., & Herman, I. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00389.2001 · Cited by 809
Cited by
Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshita, T., Saito, N., Ochiai, A., Tomita, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4806 · Cited by 956
Self-citationXanthones from Fungi, Lichens, and Bacteria: The Natural Products and Their Synthesis
Masters, K.-S., & Bräse, S. (2012) · Chemical Reviews · doi:10.1021/cr100446h · Cited by 415
Awale, S., Lu, J., Kalauni, S. K., Kurashima, Y., Tezuka, Y., Kadota, S., & Esumi, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3143 · Cited by 330
Self-citationl‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth
Oda, K., Hosoda, N., Endo, H., Saito, K., Tsujihara, K., Yamamura, M., Sakata, T., Anzai, N., Wempe, M. F., Kanai, Y., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01386.x · Cited by 273
Wenzel, C., Riefke, B., Gründemann, S., Krebs, A., Christian, S., Prinz, F., Osterland, M., Golfier, S., Räse, S., Ansari, N., et al. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.01.017 · Cited by 254
Metadata
- Authors
- Lu, J., Kunimoto, S., Yamazaki, Y., Kaminishi, M., & Esumi, H.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2004-06
- Volume
- 95
- Issue
- 6
- Pages
- 547-552
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W2015421371
- Cited by
- 107
- References
- 1
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Kigamicin D, a novel anticancer agent based on a new anti‐austerity strategy targeting cancer cells' tolerance to nutrient starvation. https://app.cochat.ai/papers/10.1111/j.1349-7006.2004.tb03247.x
- The paper
- Lu, J., Kunimoto, S., Yamazaki, Y., Kaminishi, M., & Esumi, H. (2004). Kigamicin D, a novel anticancer agent based on a new anti‐austerity strategy targeting cancer cells' tolerance to nutrient starvation. Cancer Science. https://doi.org/10.1111/j.1349-7006.2004.tb03247.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.